{'fraction_non_alphanumeric': 0.0285204991087344, 'fraction_numerical': 0.0, 'mean_word_length': 6.113924050632911, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Observational study of corrected count increments after transfusion of platelets treated with riboflavin pathogen reduction technology in additive solutions

Mirasol pathogen reduction technology (PRT) treatment inactivates bacteria, viruses, and parasites in plasma products and platelets (PLTs) suspended in plasma and PLT additive solutions (PAS). Few clinical studies exist documenting transfusions with PAS. This study objective was to evaluate the count increments of PRT‐treated PAS‐C and PAS‐E buffy coat (BC) PLTs in routine use observational settings.